Primary testicular lymphoma: a clinical analysis of 16 cases
10.3760/cma.j.issn.1009-9921.2019.11.004
- VernacularTitle: 原发睾丸淋巴瘤16例临床分析
- Author:
Yuqing MIAO
1
;
Yongfen HUANG
1
;
Lei FAN
2
;
Wei XU
2
;
Jianyong LI
2
;
Hao XU
1
Author Information
1. Department of Hematology, Yancheng No.1 People's Hospital, Yancheng 224000, China
2. Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China
- Publication Type:Journal Article
- Keywords:
Testicular neoplasms;
Lymphoma;
Orchiectomy;
Combined modality therapy
- From:
Journal of Leukemia & Lymphoma
2019;28(11):658-662
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the clinicopathological features and therapeutic regimens of primary testicular lymphoma (PTL).
Methods:The clinical data of 16 patients diagnosed with PTL from January 2005 to December 2015 in Jiangsu Province Hospital were collected, and the clinicopathological characteristics were retrospectively analyzed. Kaplan-Meier method was used to make the survival analysis.
Results:The median onset age of 16 patients was 63 years old (33-81 years old). According to Ann Arbor stage, there were 8 cases of stage ⅠE, 2 cases of stage ⅡE, 6 cases of stage Ⅲ-Ⅳ. The initial symptoms included painless solid enlargement of the testis (9 cases), painful testis (3 cases), distending pain of testis (1 case), and the patients had no other systemic symptoms. The pathological type was diffuse large B-cell lymphoma (DLBCL), of which 2 patients were germinal center B-cell (GCB) type and the other 14 patients were non-GCB type. All the patients received the orchiectomy, of which 14 received chemotherapy alone after the operation, 2 received chemotherapy and radiotherapy. Complete follow-up data were available for 14 patients, and the median follow-up time was 23.5 months (1.0-97.0 months). Among 14 patients, complete remission was achieved in 11 patients, partial remission in 1 patient, no response in 1 patient, and 1 patient was undergoing treatment. Among 11 patients with complete remission, 5 patients relapsed, and the recurrence occurred at the central nervous system (3 cases), skin of right lower extremity (1 case), and contralateral testis (1 case). The mean progression-free survival (PFS) time was 19.0 months (14.0-95.0 months).
Conclusions:Most PTL is primary testis DLBCL, and the comprehensive treatment based on surgery is the main therapy of PTL. Postoperative chemotherapy with or without radiotherapy is recommended to prevent relapse.
